Reset
Showing 5 of 5 academic articles

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review

Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar • Bioinorganic Chemistry and Applications (2021)

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can lead to end-stage liver disease needing a liver transplant. Many pharmacological approaches are used to reduce the disease progression in NAFLD. However, cu...

DOAJ Open Access (DOAJ) DOI: 10.1155/2021/4041415

Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice

Clinton M. Hasenour, Arion J. Kennedy, Tomasz Bednarski, Irina A. Trenary et al. • Journal of Lipid Research (2020)

Fatty liver involves ectopic lipid accumulation and dysregulated hepatic oxidative metabolism, which can progress to a state of elevated inflammation and fibrosis referred to as nonalcoholic steatohepatitis (NASH). The factors that control ...

DOAJ Open Access (DOAJ) DOI: 10.1194/jlr.RA119000183

Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease

Hewei Peng, Junchao Zhang, Xianhua Huang, Miao Xu et al. • Lipids in Health and Disease (2023)

Abstract Background Nonalcoholic fatty liver disease (NAFLD), a common liver disease worldwide, can be reversed early in life with lifestyle and medical interventions. This study aimed to develop a noninvasive tool to screen NAFLD accuratel...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12944-023-01808-0